HGH Peptides: What They Are, How They Work, and What to Expect

Your body made plenty of growth hormone at 25. By the time you're 40, it's making roughly half as much. By 50, you're down to about a third of your peak output. And unlike testosterone, where you might get a referral and a prescription, most doctors don't test growth hormone at all.

So people are figuring out HGH peptides themselves. They're reading about sermorelin and ipamorelin on Reddit. They're watching YouTube videos about CJC-1295. They're buying peptides from gray-market suppliers because they can't find a physician who takes this seriously.

This guide is for those people. We're going to cover what growth hormone peptides actually are, which ones have real clinical data behind them, which ones are mostly theoretical at this point, and how to access them through a licensed physician rather than a research chemical supplier.

What Are HGH Peptides, and How Do They Work?

HGH peptides aren't growth hormone. That's the first thing to understand. They're signaling compounds that tell your pituitary gland to release more of its own growth hormone. Your body still does the work. These peptides just turn up the signal.

There are two main mechanisms, and understanding the difference matters for choosing a protocol:

GHRH analogs (sermorelin, CJC-1295, tesamorelin) work by mimicking growth hormone-releasing hormone, the signal that travels from your hypothalamus to your pituitary. When you inject sermorelin, you're essentially sending that "release GH" message directly.

GHRPs (growth hormone releasing peptides) like ipamorelin, GHRP-6, and GHRP-2 work differently. They mimic ghrelin, the hunger hormone, and bind to a separate receptor on the pituitary. The result is still a GH pulse, but through a different pathway.

Why does this matter? Because the two pathways work synergistically. A GHRH analog plus a GHRP creates a bigger GH pulse than either one alone. That's why you see so many protocols pairing CJC-1295 with ipamorelin: the combination produces a stronger, more physiological release.

The outcome of all this signaling is a rise in IGF-1, the downstream hormone that drives most of growth hormone's effects on muscle, fat metabolism, and tissue repair. Thomas DeLauer and Dr. Kyle Gillett (DeLauer, 2025) have discussed how CJC-1295 and ipamorelin can produce a 1.5x to 3x increase in IGF-1, with that elevation persisting for up to 28 days after consistent use.

HGH Peptides: What's Legal, What's Not

This is where most articles get vague. Let's be specific.

Tesamorelin (brand name EGRIFTA SV) is the only growth hormone peptide with FDA approval. That approval is narrow: it's indicated specifically for reduction of excess abdominal fat in HIV-infected adults with lipodystrophy. It is not FDA-approved for general fat loss, anti-aging, or body composition improvement in otherwise healthy adults.

Off-label use for visceral fat reduction is occurring in clinical practice, but anyone telling you tesamorelin is "FDA-approved for fat loss" is giving you incomplete information.

Sermorelin had a different story. It was previously FDA-approved under the brand name Geref for pediatric growth hormone deficiency. That approval was voluntarily withdrawn by the manufacturer, not for safety reasons, but commercial ones. Today, sermorelin is available through 503A compounding pharmacies with a physician prescription. It carries Category 2 status on the FDA's bulk drug substances list, meaning compounding is legal in states that recognize 503A pharmacies. (Walker, 2006) made the case that compounded sermorelin may actually be preferable to synthetic rhGH for adult-onset GH insufficiency, precisely because it works with the pituitary's natural pulse pattern rather than bypassing it.

Ipamorelin, CJC-1295, GHRP-6, and GHRP-2 are not FDA-approved for any indication. They're available through compounding pharmacies with physician oversight. Ipamorelin went through Phase 2 clinical trials for post-operative ileus but was never brought to market.

One thing every athlete needs to know. All growth hormone secretagogues, every peptide on this list, are prohibited in competitive sport under the World Anti-Doping Agency's S2 category. This applies to sermorelin, ipamorelin, tesamorelin, CJC-1295, GHRP-6, and GHRP-2. Steven Wright, then-Red Sox pitcher, received an 80-game MLB suspension after testing positive for GHRP-2. If you compete in any sport with drug testing, speak with your sports medicine physician before touching any GH peptide. The WADA prohibited list updates annually; always verify current status at wada-ama.org.

The Evidence: What Each Peptide Actually Does

Not all HGH peptides have the same amount of human data behind them. Here's an honest breakdown.

Tesamorelin

The most clinically validated of the class. Multiple Phase 3 randomized controlled trials supported its FDA approval. A key trial (Falutz et al., 2007) showed significant reduction in visceral adipose tissue in HIV-infected patients. The mechanism (stimulating pulsatile GH release from the pituitary) is well established, and because it works through the body's own regulatory systems, the GH elevation stays within physiological ranges rather than creating the supraphysiological levels seen with direct rhGH injection.

The adverse event database for tesamorelin (EGRIFTA SV) contains 3,356 reports (FDA FAERS, 2024). Most are mild: injection site reactions, numbness, tingling, joint pain, dizziness. There have been 100 serious adverse event reports. This is the safety data that exists for the approved form. Compounded peptides have essentially no post-market surveillance.

Sermorelin

The best evidence for off-label adult use comes from (Vittone et al., 1997), which looked at nightly GHRH(1-29) injections in healthy elderly men and found improved body composition and GH secretion patterns. (Walker, 2006) reviewed the clinical literature and argued sermorelin's advantages over direct rhGH: it preserves the body's own regulatory feedback loops, it doesn't suppress endogenous GH production, and the pituitary still applies its natural safety checks on how much GH gets released.

(Sigalos & Pastuszak, 2018), reviewing the safety and efficacy of growth hormone secretagogues in Sexual Medicine Reviews, found the general safety profile to be acceptable but noted the need for more long-term human data.

Ipamorelin and CJC-1295

These are widely used in clinical practice, but the human evidence is limited. Most of what's published is animal or in vitro data. Ipamorelin's appeal is its selectivity: it produces a GH pulse without significantly raising cortisol, prolactin, or ACTH the way GHRP-6 does. That selectivity is one reason it's become the preferred GHRP in many physicians' protocols.

CJC-1295 exists in two forms: with DAC (drug affinity complex) and without. The DAC version has a much longer half-life, maintaining elevated GH and IGF-1 for up to two weeks with a single injection. Without DAC, the half-life is closer to sermorelin's, with a rapid peak and faster clearance. The blunted pulse pattern from DAC formulations concerns some physicians who prefer the more natural pulsatile release of the no-DAC version.

(Svensson et al., 2000) studied MK-677, an oral GH secretagogue with a similar ghrelin-mimetic mechanism to ipamorelin, and found significant increases in GH secretion, fat-free mass, and energy expenditure over two months. This is often cited as indirect support for the GHRP class, though MK-677 is a distinct compound.

GHRP-6 and GHRP-2

These are the older generation of GHRPs. They produce strong GH pulses but also significantly stimulate ghrelin, which means intense hunger. GHRP-6 in particular is known for producing strong appetite stimulation shortly after injection. They also raise cortisol and prolactin more than ipamorelin does. In most clinical protocols, they've largely been replaced by ipamorelin for this reason.

What HGH Peptides Can and Can't Do

Set realistic expectations before considering any of these compounds.

What the evidence supports, at least for the better-studied compounds (Sigalos & Pastuszak, 2018):

• Improved sleep quality, particularly slow-wave sleep (GHRH promotes deep sleep; this is well established)
• Modest body composition improvements over months of consistent use, including some reduction in visceral fat and some increase in lean mass
• Improved recovery from training and injury
• Better skin quality and some degree of anti-aging effects at the tissue level

What the evidence does NOT support:

• Rapid fat loss comparable to GLP-1 medications
• Dramatic muscle building in short time frames
• Any of the effects attributed to direct synthetic HGH injection

The (Rosenfalck et al., 2000) study of actual growth hormone replacement in GH-deficient adults over 30 months is instructive here. Participants on low-dose rhGH saw a 10% increase in lean body mass and a 12% reduction in fat mass. Meaningful, but not dramatic. Peptides that stimulate GH indirectly produce more modest GH elevations. The body composition results will be proportionally more modest and happen over a longer time frame.

The cancer question. This comes up regularly in community discussions, and it deserves a direct answer. Growth hormone and IGF-1 promote cell growth. That's the mechanism that makes them useful. It's also theoretically the mechanism by which they could accelerate growth of existing tumors. (Huberman, 2022) raised this point: if there's a small cancer you don't know about, elevating GH and IGF-1 could accelerate it.

The current evidence doesn't establish a causal link between GH peptides and cancer in otherwise healthy adults, but long-term safety data in healthy populations is essentially nonexistent. The theoretical concern is real enough that anyone with a personal or family history of hormone-sensitive cancers should have a detailed conversation with their physician before starting any GH peptide protocol. This isn't a reason to avoid them categorically. It's a reason to do this under physician supervision, not from a gray-market supplier.

Typical Protocols: What Physicians Use

This is for context, not as a prescription. Every protocol needs to be calibrated to your labs, your goals, and your health history.

Sermorelin: Typically 200-500mcg subcutaneous injection, nightly before sleep. Administered at night because GH naturally peaks during slow-wave sleep, and the injection amplifies the natural pulse.

CJC-1295 + Ipamorelin: The most commonly prescribed combination. CJC-1295 (no DAC) at 100-300mcg paired with ipamorelin at 100-300mcg, injected together before sleep. Some protocols add a morning injection to increase total daily GH exposure.

Tesamorelin: FDA-approved dosing is 2mg subcutaneous injection daily.

Blood work matters here. AACE/ACE guidelines (Yuen et al., 2019) recommend monitoring IGF-1 levels before starting and throughout any GH-related protocol. Too high for too long isn't the goal. Staying in the upper-normal range for your age is. That requires labs, not guesswork.

Most physicians recommend cycling these peptides, 3 to 6 months on and 1 to 2 months off, to prevent receptor desensitization and preserve the pituitary's natural response.

How Long Until You Notice Something?

Most people notice improved sleep quality within the first 2-4 weeks. The GH-sleep connection is real (Steiger & Holsboer, 1997) and often the first tangible result: deeper sleep, more vivid dreams, waking feeling genuinely rested rather than just not tired.

Energy and recovery improvements typically follow over weeks 4-8. Body composition changes are measurable around the 3-month mark, with full results developing over 6-12 months. Anyone promising visible fat loss results in 30 days is overpromising.

Cost, Coverage, and How to Access HGH Peptides

Be clear-eyed about this before you start.

Tesamorelin (EGRIFTA SV): Covered by some insurance plans for its approved indication (HIV lipodystrophy). Without insurance, the cost is significant, as this is a branded pharmaceutical. Off-label prescribing is possible but you'll likely pay out of pocket.

Compounded peptides (sermorelin, ipamorelin, CJC-1295): Insurance does not cover these. Cash-pay pricing through legitimate compounding pharmacies and telehealth providers typically runs $50-400 per month depending on the compound, dosage, and provider.

One important warning about sourcing: Ryan Humiston sent commercially available "research peptide" products to independent analytical labs and found major discrepancies. One product claimed 60mg but contained 108mg, which is 180% of the label claim. That's not a quality control win; it's evidence that there's no quality control at all. At incorrect concentrations, you don't know what you're actually injecting.

The legal and safest path runs through a licensed physician who can prescribe through a 503A compounding pharmacy with Certificate of Analysis documentation for every batch (Prakash & Goa, 1999). It's not free, but it's the difference between knowing what's in your syringe and guessing.

At HEXIS, this process starts with labs: an IGF-1 baseline, a full metabolic panel, and a conversation about your goals and health history. Then your physician builds a protocol around your numbers, not a generic template. If you want to explore growth hormone peptides under physician supervision, schedule a consultation.

Also worth reading: our guide to sermorelin before and after results for real-world expectations, and peptides for weight loss if body composition is your primary goal. We also cover BPC-157 benefits for those interested in peptides for injury recovery and tissue repair.

Frequently Asked Questions

Is sermorelin the same as human growth hormone (HGH)?

No. Sermorelin is a 29-amino-acid analog of growth hormone-releasing hormone (GHRH). It stimulates your pituitary to release its own growth hormone; it doesn't contain or add exogenous HGH. Direct synthetic HGH bypasses the pituitary entirely. Sermorelin works through it. That distinction matters because sermorelin preserves the pituitary's natural safety checks and produces a more physiological GH pattern than injecting synthetic hormone.

Should I use CJC-1295 with ipamorelin or alone?

Most physicians prescribe them together for a reason. CJC-1295 (a GHRH analog) and ipamorelin (a GHRP) work through different receptor pathways and produce a synergistic GH pulse when combined. The combination consistently produces larger GH elevations than either compound alone. CJC-1295 without the GHRP component provides a weaker stimulus. The combination is standard in most clinical protocols.

Can athletes use sermorelin or ipamorelin?

No, not if they're subject to drug testing. All growth hormone secretagogues are prohibited in competitive sport under WADA's S2 category. This prohibition covers sermorelin, ipamorelin, tesamorelin, CJC-1295, GHRP-6, GHRP-2, and related compounds. An 80-game MLB suspension was handed to Steven Wright for testing positive for GHRP-2. The WADA prohibited list updates annually; verify current status before using any GH peptide if you compete.

What are the side effects of growth hormone peptides?

The most commonly reported side effects include water retention (especially early in a protocol), joint discomfort, tingling or numbness at injection sites, and transient hunger (particularly with GHRP-6). Some people experience morning grogginess early on, which typically resolves. Elevated blood sugar is a concern with sustained IGF-1 elevation, which is why fasting glucose and HbA1c are worth monitoring on any extended protocol. The FAERS database for tesamorelin shows the most common serious adverse events include injection site reactions, arthralgias, and paresthesias.

How do I get HGH peptides legally in the US?

You need a physician's prescription. Tesamorelin requires a prescription and is available at pharmacies. Sermorelin, ipamorelin, and CJC-1295 require a prescription from a physician who will then route you to a licensed 503A compounding pharmacy. Purchasing peptides labeled "for research use only" from online vendors without a prescription is legally gray at best, and the quality control issues are well documented. The physician-supervised path is both safer and legal.